Saúde
Semaglutida: Anvisa aprova o uso da primeira injeção para tratar sobrepeso e obesidade
Medicação conseguiu reduzir uma média de 17% do peso corporal nos pacientes em 68 semanas
A Anvisa (Agência Nacional de Vigilância Sanitária) aprovou, na segunda-feira (2), o Wegovy (semaglutida 2,4mg), primeiro medicamento injetável para tratar sobrepeso e obesidade. Comercializada nos Estados Unidos desde 2021, a injeção deve ser aplicada semanalmente para garantir o tratamento dos pacientes.
Segundo resultados do programa de ensaios clínicos STEP (Semaglutide Treatment Effect in People with Obesity), realizado com cerca de 4,5 mil pessoas ao redor do globo, a medicação conseguiu reduzir uma média de 17% do peso corporal nos pacientes em 68 semanas.
A decisão da Anvisa foi publicada no Diário Oficial da União. O Wegovy tem o mesmo princípio ativo do Ozempic, indicado pela agência em julho do ano passado para tratamento de diabetes tipo 2, mas será utilizado para pacientes com sobrepeso e obesidade.
Ele funciona como um inibidor de apetite, sendo análogo ao GLP-1, hormônio que pode ser encontrado no intestino. Ou seja, toda vez que o paciente comer, o remédio vai enviar um sinal para o cérebro indicando que é hora de reduzir a fome.
Além disso, o medicamento deve ajudar a retardar o esvaziamento do estômago e aumentar a produção de insulina. Apesar da novidade, ainda não há uma data definida para que a Semaglutida comece a ser comercializada no mercado brasileiro.
Por Portal Folha de Pernambuco
I loved as much as you will receive carried
out right here. The sketch is tasteful, your authored material stylish.
nonetheless, you command get got an edginess over that you wish be delivering the following.
unwell unquestionably come further formerly again since exactly the same nearly very often inside case you
shield this increase.
Truly no matter if someone doesn’t know after that its
up to other viewers that they will help, so here it occurs.
Nice post. I learn something new and challenging on sites I stumbleupon on a daily basis. It will always be useful to read through content from other writers and practice something from other websites.
Awesome blog you have here but I was wanting to know if you knew of any user discussion forums that cover the same topics talked about here?
I’d really like to be a part of online community where I can get advice from other experienced people that share the same interest.
If you have any recommendations, please let me know. Bless you!
I go to see daily a few websites and blogs to read articles or reviews,
but this blog offers feature based posts.
Oh my goodness! Awesome article dude! Many thanks, However I am experiencing issues with your RSS. I don’t understand why I can’t subscribe to it. Is there anybody else having identical RSS issues? Anyone that knows the answer can you kindly respond? Thanks!!
Hi there, I found your website by the use of Google
while looking for a comparable topic, your site came up, it looks great.
I’ve bookmarked it in my google bookmarks.
Hello there, simply changed into alert to your weblog via Google, and found that it’s really informative.
I am gonna watch out for brussels. I will
be grateful in the event you continue this in future.
Numerous people will probably be benefited out of
your writing. Cheers!
After I initially commented I appear to have clicked the -Notify me when new comments are added- checkbox and now every time a comment is added I receive four emails with the same comment. Perhaps there is an easy method you are able to remove me from that service? Thanks!
Hello there! This article couldn’t be written any better!
Looking through this post reminds me of my previous roommate!
He constantly kept talking about this. I
most certainly will forward this post to him. Fairly certain he will have a very good read.
Thank you for sharing!
This is a really good tip particularly to those new to the blogosphere. Simple but very precise information… Thank you for sharing this one. A must read article!